NCT05254561View on ClinicalTrials.gov

Triple Antigen vs Monoantigen Immunotherapy for Warts

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

November 20, 2020

Primary Completion Date

June 20, 2021

Study Completion Date

November 15, 2021

Conditions
Triple Intralesional Immunotherapy Combination in Multiple Recalcitrant Warts
Interventions
BIOLOGICAL

Intralesional antigen immunotherapy

Randomized double-blinded comparative effectiveness and safety clinical trial

Trial Locations (1)

44519

Zagazig university, Zagazig

All Listed Sponsors
lead

Zagazig University

OTHER_GOV

NCT05254561 - Triple Antigen vs Monoantigen Immunotherapy for Warts | Biotech Hunter | Biotech Hunter